DrugPatentWatch Database Preview
Sagent Pharms Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for SAGENT PHARMS, and what generic and branded alternatives to SAGENT PHARMS drugs are available?
SAGENT PHARMS has sixty-eight approved drugs.
There is one tentative approval on SAGENT PHARMS drugs.
Summary for Sagent Pharms
| US Patents: | 0 |
| Tradenames: | 54 |
| Ingredients: | 52 |
| NDAs: | 68 |
Drugs and US Patents for Sagent Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms | LEUCOVORIN CALCIUM PRESERVATIVE FREE | leucovorin calcium | INJECTABLE;INJECTION | 200753-003 | Sep 6, 2012 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | IBANDRONATE SODIUM | ibandronate sodium | INJECTABLE;INTRAVENOUS | 202235-001 | Sep 2, 2014 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | CLINDAMYCIN PHOSPHATE | clindamycin phosphate | INJECTABLE;INJECTION | 090109-001 | Sep 30, 2011 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 090808-002 | Jun 30, 2010 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
